Jing Xuan Lim

Jing Xuan Lim

Auto-generated profile, based on publicly available information

Jing Xuan Lim

Biosciences Institute, Newcastle University 1 Faculty of Medical Sciences Newcastle Upon Tyne

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
JLJing Xuan Lim
Jing Xuan Lim
TMTegan McTaggart
Tegan McTaggart
SJSeol Kyoung Jung
Seol Kyoung Jung
KSKatie J. Smith
Katie J. Smith
GHGillian Hulme
Gillian Hulme
SAShoba Amarnath
Shoba Amarnath
Regulatory T (Treg) cells are vital for immune suppression. The role of the coreceptor programmed cell death 1 receptor (PD-1) in Treg cell function is controversial. Here, we demonstrate that PD-1 deficiency enhances the function of Treg cells through expression of a compensatory network of coinhibitory receptors. CD30 has a central role within this network, driving the Treg cell suppressive function within the tumor microenvironment. Mechanistically, PD-1 deficiency enhances STAT5 signaling in Treg cells, which induces CD30 expression. These data indicate a role for PD-1 as a checkpoint that negatively controls CD30 expression in Treg cells to limit their suppressive function. Understanding the functional changes that PD-1 has on Treg cells might enable combination therapies with better treatment outcomes in cancer.

9 December 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TMTegan McTaggart
Tegan McTaggart
JLJing Xuan Lim
Jing Xuan Lim
KSKatie J. Smith
Katie J. Smith
BHBronagh Heaney
Bronagh Heaney
DMDavid McDonald
David McDonald
SAShoba Amarnath
Shoba Amarnath
Regulatory T cells (Tregs) are immune regulatory T cells that are vital for controlling inflammation. The role of Tregs in inflammatory diseases namely psoriatic arthritis (PsA) is still poorly understood. The underlying reason being a lack of robust unbiased analysis to test the immune regulatory phenotype of human Tregs. Here, we propose that checkpoint receptors can identify functional Tregs in PsA. Using unbiased BD Rhapsody single-cell analysis, we have analyzed the expression pattern of checkpoint receptors in Tregs and found that PsA Tregs are enriched in the expression of CTLA4, TIGIT, PD-1, and GITR while TIM3 was downregulated. Furthermore, PD-1+ Tregs in PsA had an increased type 1 phenotype and expressed the protease asparaginyl endopeptidase. By harnessing the PD-1 signaling pathway and inhibiting asparaginyl endopeptidase, PsA Treg function was significantly enhanced in in vitro suppressor assays. Next, we interrogated the cell interaction pathways of Tregs in PsA and found a diminished crosstalk with circulating osteoclast precursors through the CD244-CD48 coreceptor pathways. Therapeutically, PsA Treg function could be enhanced by modulating PD-1 and osteoclast interactions. Our study suggests that unconventional immune cell crosstalk with Tregs is severely diminished in PsA.

21 October 2026 in Journal of Human Immunity
Verified
Journal Article
Open access
TMTegan McTaggart
Tegan McTaggart
JLJing Xuan Lim
Jing Xuan Lim
AAArda Akchengel
Arda Akchengel
KSKatie Smith
Katie Smith
SLSophia Landell-Wright
Sophia Landell-Wright
ALArian Laurence
Arian Laurence
Cytotoxic T lymphocyte–associated antigen-4 (CTLA4) is an inhibitory co-receptor. We report a homozygous variant in CTLA4 residing in the 3′UTR of the CTLA4 gene. The patient was deficient in peripheral blood T regulatory cells that was partially reversed with abatacept.